evolva holding sa (EVE) Snapshot

Evolva Holding SA. announced consolidated earnings results for the year ended December 31, 2012. For the year, the company reported total income of CHF 7,014,442 against CHF 11,080,221 a year ago. Operating loss was CHF 20,053,757 against CHF 25,935,053 a year ago. Net loss before tax was CHF 18,155,610 against CHF 24,054,628 a year ago. Net loss attributable to shareholders of the parent was CHF 16,089,948 or CHF 0.09 per basic and diluted share against CHF 22,451,971 or CHF 0.14 per basic and diluted share a year ago. Net cash outflow from operating activities was CHF 13,445,766 against CHF 17,402,435 a year ago. Purchases of property, plant and equipment were CHF 491,132 against CHF 965,325 a year ago. The company provided earnings guidance for 2013. The company expects revenues in 2013 to increase to CHF 10-13 million against CHF 7 million in 2012. Operating costs are expected to increase as a consequence of new R&D partnerships, additional investment in internal projects (incl. the stevia project partnered with Cargill) as well as financing costs. The net cash out-flow from operating and investing activities is expected to be approximately CHF 12-15 million.

Evolva Holding SA., 2012 Earnings Call, Apr 09, 2013

Evolva Holding SA. announced that it has entered into an agreement with Cargill, Incorporated to jointly develop and commercialize fermentation-derived steviol glycosides. Cargill will be responsible for commercialization and has agreed to make a CHF 5 million (approximately USD 5.3 million) equity investment in Evolva. Additionally, Evolva stands to receive up to USD 7.5 million in milestone payments and has the right to a 45% participation in the final business. If Evolva decides not to exercise this option it will receive royalty payments from global sales of the co-developed steviol glycoside products; these royalties will scale from mid-single digit to low double-digit percentages as a function of sales volume and other parameters. Cargill brings to the collaboration its vast manufacturing and commercial expertise in bulk sweeteners, food ingredients, and of course stevia sweeteners.